Literature DB >> 12870833

Determinants of dyspnea in patients with different grades of stable asthma.

Eva Martínez-Moragón1, Miguel Perpiñá, Amparo Belloch, Alfredo de Diego, Manuela Martínez-Francés.   

Abstract

Dyspnea is a main feature of symptomatology in asthma, and its perception does not necessarily correlates well with airway obstruction. The aim of this study was twofold: (1) to identify factors determining the subjective degree of dyspnea in patients with different grades of stable bronchial asthma and (2) to compare various clinical methods existing for grading dyspnea. The investigation comprised 153 outpatients with stable asthma. The parameters studied were the following: demographic characteristic of subjects, baseline dyspnea score by means of three clinical instruments (baseline dyspnea index [BDI], Medical Research Council [MRC] scale, and modified Borg scale), asthma severity, standard measures of physiologic lung function, anxiety, depression, subconscious illness attention, and asthma-related quality of life (HRQOL). The dyspnea scores were all significantly interrelated (r=0.77-0.85, p<0.001). The three clinical scales for grading dyspnea were significantly correlated with the same parameters: airflow obstruction, lung hyperinflation, emotional factors, HRQOL, age, age at asthma onset, asthma duration, female gender, clinical severity, and lower economical, and educational levels. Multiple regression analysis showed that independent factors determining clinical dyspnea scores were: age, airway obstruction, and emotional status. Moreover, in patients with severe asthma, lung hyperinflation helped to explain the individual dyspnea score. These data suggest that clinical methods are appropriate for evaluating the impact of dyspnea on daily activities of asthmatic patients. BDI, MRC, and Borg clinical dyspnea scales showed similarly information in subjects with asthma. Independently of asthma severity, older age, airway obstruction, and psychological disturbance were associated with higher degree of dyspnea. However, if subjects had severe airway obstruction, lung hyperinflation was a major determinant of baseline dyspnea score.

Entities:  

Mesh:

Year:  2003        PMID: 12870833     DOI: 10.1081/jas-120018637

Source DB:  PubMed          Journal:  J Asthma        ISSN: 0277-0903            Impact factor:   2.515


  7 in total

1.  Usefulness of the culturally adapted oxygen-cost diagram in the assessment of dyspnea in Puerto Rico.

Authors:  Yohana De Jesús-Berrios; Ruth A Santos-Rodríguez; Donald Dexter; Mariely Nieves-Plaza; Cruz M Nazario
Journal:  P R Health Sci J       Date:  2015-03       Impact factor: 0.705

2.  Incentive spirometry as a means to score breathlessness.

Authors:  Li-Cher Loh; Pek-Ngor Teh; Sree Raman; Pillai Vijayasingham; Tarmizi Thayaparan
Journal:  Malays J Med Sci       Date:  2005-01

3.  Noninvasive tests for the diagnostic evaluation of dyspnea among outpatients: the Multi-Ethnic Study of Atherosclerosis lung study.

Authors:  Elizabeth C Oelsner; Joao A C Lima; Steven M Kawut; Kristin M Burkart; Paul L Enright; Firas S Ahmed; R Graham Barr
Journal:  Am J Med       Date:  2014-10-15       Impact factor: 4.965

4.  Fibromyalgia in Iraqi patients with asthma and its impact on asthma severity and control.

Authors:  Faiq I Gorial; Manal Abbas Allawerdi; Mustafa Neeama Abd Ali
Journal:  Ann Med Surg (Lond)       Date:  2020-10-16

5.  Asthma and Mood Disorders.

Authors:  Anupama Kewalramani; Mary E Bollinger; Teodor T Postolache
Journal:  Int J Child Health Hum Dev       Date:  2008

6.  Psycho-Physiological Associates of Dyspnea in Hospitalized Patients with Interstitial Lung Diseases: A Cross-Sectional Study.

Authors:  Yan Hua Zhou; Yim Wah Mak
Journal:  Int J Environ Res Public Health       Date:  2017-10-24       Impact factor: 3.390

7.  Evidence for mood-dependent attentional processing in asthma: attentional bias towards health-threat in depressive mood and attentional avoidance in neutral mood.

Authors:  Iana Alexeeva; Maryanne Martin
Journal:  J Behav Med       Date:  2018-04-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.